128 related articles for article (PubMed ID: 14157082)
1. COMPARATIVE CARDIAC EFFECTS OF QUINIDINE AND N,N-BIS(PHENYLCARBAMOYLMETHYL)-DIMETHYLAMMONIUM CHLORIDE (QX-572), A NEW ANTIARRHYTHMIC AGENT.
COVINO BG; RACHWALL P
J New Drugs; 1964; 4(1):30-7. PubMed ID: 14157082
[No Abstract] [Full Text] [Related]
2. ANTIARRHYTHMIC ACTION OF N, N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYL AMMONIUM CHLORIDE (QX-572) IN CAT AND DOG.
KATZ RL
Anesthesiology; 1964; 25():291-6. PubMed ID: 14156568
[No Abstract] [Full Text] [Related]
3. [Comparative studies of the antiarrhythmic activity of prolonged action quaternary ammonium derivatives of trimecaine (G-104) and lidocaine (QX-572)].
Kostin IaV; Fillipov AK; Grenader AK; Gendenshteĭn EI; Porotikov VI
Farmakol Toksikol; 1987; 50(6):45-7. PubMed ID: 3436423
[TBL] [Abstract][Full Text] [Related]
4. SOME OBSERVATIONS OF ANTIFIBRILLATORY AGENTS ON VENTRICULAR FIBRILLATION UNDER HYPOTHERMIA.
SAXENA JP
Indian J Physiol Pharmacol; 1963 Oct; 7():235-9. PubMed ID: 14175614
[No Abstract] [Full Text] [Related]
5. SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.
CONN HL; LUCHI RJ
Am J Med; 1964 Nov; 37():685-99. PubMed ID: 14237425
[No Abstract] [Full Text] [Related]
6. NONUNIFORM RECOVERY OF EXCITABILITY IN VENTRICULAR MUSCLE.
HAN J; MOE GK
Circ Res; 1964 Jan; 14():44-60. PubMed ID: 14104163
[No Abstract] [Full Text] [Related]
7. Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.
Schwartz ML; Stapleton J; Covino BG
J Clin Pharmacol J New Drugs; 1967; 7(5):278-86. PubMed ID: 5237375
[No Abstract] [Full Text] [Related]
8. IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION.
MELVILLE KI; SHISTER HE; HUQ S
Can Med Assoc J; 1964 Mar; 90(13):761-70. PubMed ID: 14132168
[TBL] [Abstract][Full Text] [Related]
9. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
[TBL] [Abstract][Full Text] [Related]
10. ELECTROPHYSIOLOGIC ANTAGONISM AND SYNERGISM OF POTASSIUM AND ANTIARRHYTHMIC AGENTS.
WATANABE Y; DREIFUS LS; LIKOFF W
Am J Cardiol; 1963 Nov; 12():702-10. PubMed ID: 14076002
[No Abstract] [Full Text] [Related]
11. [RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].
LINDNER E
Arch Int Pharmacodyn Ther; 1963 Dec; 146():485-500. PubMed ID: 14103285
[No Abstract] [Full Text] [Related]
12. [EFFECTS OF SYNTHETIC LYSL-8-VASOPRESSIN ON ADRENALINE-CHLOROFORM ARRHYTHMIAS IN THE ANESTHETIZED DOG].
BRODEUR J; BEAULNES A
Rev Can Biol; 1964 Mar; 23():37-44. PubMed ID: 14147529
[No Abstract] [Full Text] [Related]
13. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
Kostin IaV; Blinov DS; Moiseeva IIa
Eksp Klin Farmakol; 2003; 66(3):29-31. PubMed ID: 12924229
[TBL] [Abstract][Full Text] [Related]
14. Comparative myocardial depressant effects of lidocaine, ajmalin, propranolol and quinidine.
Tomoda H; Chuck L; Parmley WW
Jpn Circ J; 1972 May; 36(5):433-7. PubMed ID: 5068725
[No Abstract] [Full Text] [Related]
15. Comparison of the effects of intravenous LNC-834, a new antiarrhythmic agent, and quinidine in canine models of arrhythmia.
D'Alonzo AJ; Butterfield JL; Drexler AP; Sergio SL
J Cardiovasc Pharmacol; 1990 Sep; 16(3):506-17. PubMed ID: 1700225
[TBL] [Abstract][Full Text] [Related]
16. QUATERNARY DERIVATIVES OF AMINOACYLANILINES. II.N,N-BIS(ARYLCARBAMOYLALKYL)AMMONIUM SALTS, A CLASS OF NEW COMPOUNDS WITH ANTI-ARRHYTHMIC ACTIVITY.
DAHLBOM R; MISIORNY A; TRUANT AP; DAMATO HE; MASCHOUF C
Acta Pharm Suec; 1965 Jun; 2():219-26. PubMed ID: 14326396
[No Abstract] [Full Text] [Related]
17. Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
Bergdahl B; Karlsson E; Magnusson JO; Sonnhag C
Acta Med Scand; 1978; 204(4):311-4. PubMed ID: 358766
[TBL] [Abstract][Full Text] [Related]
18. [Change in the fibrillation threshold of auricular and ventricular musculature of isolated mammalian heart after cooling and after administration of various pharmacological agents].
SZEKERES L; LENARD G
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():454-9. PubMed ID: 13836357
[No Abstract] [Full Text] [Related]
19. Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.
Rydén L; Olsson B; Kvasnicka J
Cardiovasc Res; 1975 Jan; 9(1):81-94. PubMed ID: 1091351
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antiarrhythmic activity of quinidine and quinine.
Klevans LR; Kelly RJ; Kovacs JL
Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
